Médiane de surive 47 mois
Temps avant un nouveau traitement 21 mois
Attention les statistiques concerne des malades dont la moyenne d'age est entre 60 et 70 ans
"What is the best treatment for relapsed CLL? The MDACC group makes a plea that it is still FCR. In the Blood of 17th March a final report of the large phase II study of FCR in relapsed CLL is made. The overall response rate was 74% and the CR rate 30%. The median overall survival was 47 months and progression-free survival 21 months."
Aucun commentaire:
Enregistrer un commentaire